Previous pharmacogenetic studies in psoriasis and rheumatoid arthritis have reported associations between MTX response and polymorphisms in SLC19A1, MTHFR, and ABC transporters, although the results have been inconsistent [7,8,9]. Here, SLC19A1 is linked to rheumatoid arthritis.